Novelis Inc. reports Q4 FY26 and full year 2025-26 financial results
Hindalco Industries · Non - Ferrous Metals
Key highlights
- FY26 net sales increased 7% YoY to $18.4 billion; total FRP shipments decreased 5% to 3,557kt
- Net income attributable to common shareholder was $15 million in FY26, with $476 million excluding special items, down 38% YoY
- Adjusted EBITDA declined 9% YoY to $1,645 million; adjusted free cash flow was negative $2,377 million in FY26 due to Oswego fires and capital expenditures
Why it's rated major development: the year-on-year change is 100% (20% or more for adverse news)
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Hindalco Industries
- Capex / expansionMajor developmentHindalco Q2 FY27: Revenue up 39% to ₹91,708 Cr, PAT up 59% to ₹7,533 Cr
- Acquisition / mergerNotableHindalco Industries cancels acquisition of AluChem Companies, Inc.
- Capex / expansionNotableHindalco commissions India's first Superfine PPT ATH plant for cable fire safety
- Capex / expansionNotableHindalco announces proposed capacity expansion at Kuppam unit by FY2029
- Capex / expansionMajor developmentHindalco Industries reports Q1 FY27 consolidated unaudited financial results
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Non - Ferrous Metals
on management's own guidance
- Hindustan ZincGood growth2
- Deccan Gold MinesGood growth1
- 3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.